Yoshifumi Itoh

15.1k total citations · 2 hit papers
216 papers, 10.9k citations indexed

About

Yoshifumi Itoh is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yoshifumi Itoh has authored 216 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 75 papers in Cancer Research and 55 papers in Oncology. Recurrent topics in Yoshifumi Itoh's work include Protease and Inhibitor Mechanisms (73 papers), Peptidase Inhibition and Analysis (48 papers) and Bacterial Genetics and Biotechnology (31 papers). Yoshifumi Itoh is often cited by papers focused on Protease and Inhibitor Mechanisms (73 papers), Peptidase Inhibition and Analysis (48 papers) and Bacterial Genetics and Biotechnology (31 papers). Yoshifumi Itoh collaborates with scholars based in Japan, United Kingdom and United States. Yoshifumi Itoh's co-authors include Motoharu Seiki, Hideaki Nagase, Dieter Haas, Hidetoshi Mori, Masahiro Kajita, Akiko Okada, Hiroaki Kinoh, Takayuki Nishijyo, Yuji Nakada and Keitarou Kimura and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Yoshifumi Itoh

213 papers receiving 10.6k citations

Hit Papers

Membrane-Type 1 Matrix Me... 2001 2026 2009 2017 2001 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshifumi Itoh Japan 55 4.9k 4.2k 2.9k 1.6k 1.4k 216 10.9k
Christopher G. Knight United Kingdom 52 4.2k 0.9× 2.4k 0.6× 1.8k 0.6× 2.1k 1.3× 1.8k 1.3× 143 10.7k
Keith Brew United States 58 7.0k 1.4× 3.5k 0.8× 2.4k 0.8× 786 0.5× 1.4k 1.0× 170 13.3k
James P. Quigley United States 54 5.5k 1.1× 4.9k 1.2× 3.8k 1.3× 2.1k 1.3× 1.5k 1.1× 119 12.5k
Boris Turk Slovenia 65 7.7k 1.6× 4.6k 1.1× 3.0k 1.0× 1.0k 0.7× 683 0.5× 231 16.1k
Dieter Brömme Canada 66 7.3k 1.5× 4.7k 1.1× 3.2k 1.1× 1.1k 0.7× 955 0.7× 196 13.6k
E. Reich United States 63 7.9k 1.6× 5.1k 1.2× 2.0k 0.7× 1.2k 0.7× 2.6k 1.9× 131 15.0k
Alex Y. Strongin United States 60 5.1k 1.0× 6.2k 1.5× 4.6k 1.6× 2.2k 1.4× 2.0k 1.5× 204 13.3k
Dominique Belin Switzerland 52 8.0k 1.6× 4.2k 1.0× 1.3k 0.4× 1.2k 0.7× 2.6k 1.9× 114 15.0k
F. Xavier Gomis‐Rüth Spain 52 4.9k 1.0× 2.1k 0.5× 2.3k 0.8× 373 0.2× 691 0.5× 156 9.0k
Luciano Zardi Italy 59 6.2k 1.3× 2.6k 0.6× 3.1k 1.0× 4.8k 3.0× 632 0.5× 199 13.6k

Countries citing papers authored by Yoshifumi Itoh

Since Specialization
Citations

This map shows the geographic impact of Yoshifumi Itoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshifumi Itoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshifumi Itoh more than expected).

Fields of papers citing papers by Yoshifumi Itoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshifumi Itoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshifumi Itoh. The network helps show where Yoshifumi Itoh may publish in the future.

Co-authorship network of co-authors of Yoshifumi Itoh

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshifumi Itoh. A scholar is included among the top collaborators of Yoshifumi Itoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshifumi Itoh. Yoshifumi Itoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inada, Masaki, et al.. (2025). The Diverse Pathways for Cell Surface MT1-MMP Localization in Migratory Cells. Cells. 14(3). 209–209.
2.
Tominari, Tsukasa, R. Abe, Chiho Matsumoto, et al.. (2024). Loss of ERα involved-HER2 induction mediated by the FOXO3a signaling pathway in fulvestrant-resistant breast cancer. Biochemical and Biophysical Research Communications. 742. 151056–151056. 2 indexed citations
3.
Nandadasa, Sumeda, et al.. (2023). Degradomic Identification of Membrane Type 1-Matrix Metalloproteinase as an ADAMTS9 and ADAMTS20 Substrate. Molecular & Cellular Proteomics. 22(6). 100566–100566. 4 indexed citations
4.
Yeung, Ching‐Yan Chloé, Richa Garva, Adam Pickard, et al.. (2023). Mmp14 is required for matrisome homeostasis and circadian rhythm in fibroblasts. Matrix Biology. 124. 8–22. 6 indexed citations
5.
Itoh, Yoshifumi, Michael Ng, Akira Wiberg, et al.. (2021). A common SNP risk variant MT1-MMP causative for Dupuytren's disease has a specific defect in collagenolytic activity. Matrix Biology. 97. 20–39. 6 indexed citations
6.
Lagarto, João L., Mohammad B. Nickdel, Douglas J. Kelly, et al.. (2020). Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis. Scientific Reports. 10(1). 2154–2154. 17 indexed citations
7.
Itoh, Yoshifumi. (2017). Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies. Progress in molecular biology and translational science. 148. 327–338. 65 indexed citations
8.
Bøtkjær, Kenneth A., Hang Fai Kwok, Mikkel G. Terp, et al.. (2016). Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo. Oncotarget. 7(13). 16773–16792. 34 indexed citations
9.
Manning, Hugh B., Mohammad B. Nickdel, Kazuhiro Yamamoto, et al.. (2012). Detection of cartilage matrix degradation by autofluorescence lifetime. Matrix Biology. 32(1). 32–38. 35 indexed citations
10.
Manning, Hugh B., Abhilash Jain, Linda Troeberg, et al.. (2009). Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis & Rheumatism. 60(3). 686–697. 104 indexed citations
11.
Uji, Yukitaka, et al.. (2004). The use of color Doppler imaging in the differentiation of retinal detachment from vitreous membrane. Investigative Ophthalmology & Visual Science. 45(13). 2399–2399. 1 indexed citations
12.
Mori, Hiroyuki, Naohiko Koshikawa, Masahiro Kajita, et al.. (2002). CD44 directs membrane-type 1 matrix metalloproteinase (MT1-MMP) to lamellipodia by associating with its hemopexin-like domain (PEX). Molecular Biology of the Cell. 13. 2 indexed citations
13.
Oh, Junseo, Rei Takahashi, Shunya Kondo, et al.. (2001). The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis. Cell. 107(6). 789–800. 567 indexed citations breakdown →
14.
Heeb, Stephan, Yoshifumi Itoh, Takayuki Nishijyo, et al.. (2000). Small, Stable Shuttle Vectors Based on the Minimal pVS1 Replicon for Use in Gram-Negative, Plant-Associated Bacteria. Molecular Plant-Microbe Interactions. 13(2). 232–237. 308 indexed citations
15.
Black, Roy A., Fiona H. Durie, Robert D. Miller, et al.. (1996). Relaxed Specificity of Matrix Metalloproteinases (MMPS) and TIMP Insensitivity of Tumor Necrosis Factor-α (TNF-α) Production Suggest the Major TNF-α Converting Enzyme Is Not an MMP. Biochemical and Biophysical Research Communications. 225(2). 400–405. 60 indexed citations
16.
Sanno, N, K Inada, Hirotoshi Utsunomiya, et al.. (1994). Expression of Pit-1 product in human pituitaries: Histochemical studies using an antibody against synthetic human Pit-1 protein. Medical science research. 22(10). 685–687. 12 indexed citations
17.
Maeda, Takuya, et al.. (1991). Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist.. PubMed. 65(6). 679–87. 5 indexed citations
18.
Itoh, Yoshifumi. (1989). Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. E-CR1 levels in patients with various diseases and their correlation with B-CR1. Allergy. 38. 1276–1287.
19.
Kimura, Tomoki, et al.. (1987). Routine determination of light elements by charged-particle activation analysis. Journal of Radioanalytical and Nuclear Chemistry. 112(2). 415–423. 9 indexed citations
20.
Itoh, Yoshifumi, Y. Morishita, & Kageaki AIBARA. (1980). Changes in UV spectra and relative intensity of fluorescence of aflatoxin B1 in aqueous alkaline solutions.. 54(9). 733–740. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026